Mon.Jan 09, 2023

article thumbnail

Is It Easy Being Green?

Drug Topics

Pharmacists can make simple changes that add up to big environmental impacts.

502
502
article thumbnail

The kindred nature of martial arts and drug development

PharmaVoice

How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Terlipressin for the Management of HRS-1

Drug Topics

Approval followed resubmission of data from the phase 3 CONFIRM trial to the agency.

FDA 469
article thumbnail

Pain Management in Patients With Opioid Use Disorders

Pharmacy Times

The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.

156
156
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pilot Program From Custom Health, L.A. Care, Tackles Medication Adherence

Drug Topics

Custom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.

464
464
article thumbnail

CVS, Cigna back kidney care coordination, tech startup Monogram Health's latest $375M raise

Fierce Healthcare

CVS, Cigna back kidney care coordination, tech startup Monogram Health's latest $375M raise. dmuoio. Mon, 01/09/2023 - 12:24.

144
144

More Trending

article thumbnail

These socioeconomic factors may be indicators of long COVID risk, study says

Fierce Healthcare

These socioeconomic factors may be indicators of long COVID risk, study says. fdiamond. Mon, 01/09/2023 - 16:48.

133
133
article thumbnail

Improving Care for Every Patient: Using Clinically Relevant Data to Provide Comprehensive Care and Support Patient Outcomes

Drug Topics

While the pandemic has shined a brighter light onto the need to address social determinants of health and mental health needs, relevant data will be crucial for pharmacists to be able to help treat the whole patient.

190
190
article thumbnail

Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck

PharmaVoice

The biotech hopes to upend the CAR-T category by cutting manufacturing from weeks to hours and developing a first-line cell therapy.

130
130
article thumbnail

STAT+: FDA’s Califf says congressional report on Aduhelm controversy contained “no surprises”

STAT

SAN FRANCISCO –  U.S. Food and Drug Administration commissioner Robert Califf doesn’t disagree with the basic findings of a congressional investigation into the agency’s role in the controversial approval of Aduhelm, Biogen’s first Alzheimer’s drug. He just wishes the report’s tone had been different. “There were no surprises in the report,” Califf told STAT’s Matt Herper during a Monday night event hosted by STAT during the J.P

FDA 127
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint

Fierce Pharma

JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55.

126
126
article thumbnail

FDA Grants Priority Review to Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma

Pharmacy Times

If approved, glofitamab will treat the most aggressive type of non-Hodgkin lymphoma.

FDA 123
article thumbnail

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023

Fierce Pharma

JPM23: Moderna reaped $18.4B in COVID vaccine sales last year, projects at least $5B in 2023. kdunleavy. Mon, 01/09/2023 - 10:34.

Vaccines 123
article thumbnail

Generous Parental Leave Protects Against Poorer Mental Health, Study Results Show

Pharmacy Times

Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.

123
123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan

STAT

Senior-focused primary care providers Oak Street Health and Agilon Health used their stage time at the J.P. Morgan Healthcare Conference in San Francisco on Monday to talk up their ambitious growth plans in the coming year. Both Oak Street and Agilon’s business models are centered around the Medicare Advantage program, the private form of Medicare for people over 65.

Insurance 120
article thumbnail

Disparity Among Black, White Adults With Uncontrolled Blood Pressure

Pharmacy Times

Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.

122
122
article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First introduced in 2020, the global Managed Access Programme (gMAP) has provided Zolgensma (onasemnogene abeparvovec) free of charge to nearly 300 children with the genetic disorder across 36 countries where the therapy has not yet received approval or in which no formal access pathway exists.

119
119
article thumbnail

JPM23: Centene gears up for Medicaid redeterminations to begin this spring

Fierce Healthcare

JPM23: Centene gears up for Medicaid redeterminations to begin this spring. pminemyer. Mon, 01/09/2023 - 14:19.

106
106
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

JP Morgan 2023 – Day 1

pharmaphorum

We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning. Then in the evening, we’ll be at STAT@JPM for presentations by event sponsor GSK as well as the guest of honour: FDA Commissioner Robert Califf. Check below for updates throughout the day.

FDA 119
article thumbnail

Wakefern launches Own Brands Supplier Diversity Summit

Drug Store News

The Own Brands Supplier Diversity Summit is calling on diverse private-label manufacturers to submit products.

Labelling 105
article thumbnail

STAT+: Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.

STAT

Moderna disclosed Monday that it plans to price its Covid-19 vaccine at anywhere from $110 to $130 per dose when the company pivots from a focus on government contracts to commercial distribution efforts. The timing was not disclosed, but the company is holding talks with hospitals, pharmacy chains and pharmacy benefit managers. In setting such a price, Moderna will pursue the same path as Pfizer, which last year also announced plans to charge $110 to $130 a dose this year for its own Covid-19 s

Vaccines 104
article thumbnail

Sally Hansen enters press-on nail category

Drug Store News

Sally Hansen’s Salon Effects Perfect Manicure collection consists of ready-to-wear press-on nails that come in a variety of nail lengths, shapes, colors and designs.

105
105
article thumbnail

‘I want people to see us’: A writer gives voice to long Covid and mothering from bed

STAT

“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. Kristin Houlihan, 38, got sick in March 2020 with a virus she assumes was Covid. She wasn’t sick, in a flu-like sense, for long. But then, some symptoms never went away: night sweats, extreme temperature swings after meals.

104
104
article thumbnail

JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amyrt buyout

Fierce Pharma

JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amyrt buyout. esagonowsky. Mon, 01/09/2023 - 08:14.

100
100
article thumbnail

STAT+: Mental health data complicate the question of whether telehealth drives up costs

STAT

The surge in telehealth during the pandemic promised to shed light on a crucial question: Does the convenience of telehealth drive up costs when patients make more appointments than they would in-person? The answer stands to shape investments in — and oversight of — the fast-growing field. But three years in, the mountain of telehealth claims data has created a fresh set of questions, and left regulators, insurers, researchers, and health systems with a newfound recognition that vi

Insurance 104
article thumbnail

JPM23: Carbon Health nabs $100M, CVS Health partnership to pilot primary care in retail stores

Fierce Healthcare

JPM23: Carbon Health nabs $100M, CVS Health partnership to pilot primary care in retail stores. hlandi. Mon, 01/09/2023 - 17:28.

100
100
article thumbnail

STAT+: Rep. Jason Smith and the other Republicans leading health policy in the House

STAT

Rep. Jason Smith of Missouri will helm the powerful House Ways and Means Committee this Congress, as Republicans embark on a promised era of slashed spending and scrutiny of the pandemic response. Ways and Means oversees spending and payments for a wide range of federal health programs, often overlapping with work and legislation on other committees including Energy and Commerce.

104
104
article thumbnail

Rite Aid names Elizabeth “Busy” Burr interim CEO

Drug Store News

Heyward Donigan is departing from the company as president and CEO.

98
article thumbnail

STAT+: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers

STAT

A new study suggests physician practices acquired by private equity rely more heavily on advanced practice providers like nurse practitioners and physician assistants and experience higher churn compared with their non-private equity owned peers. The researchers used clinician-level and practice acquisition data to study changes in the makeup of clinician workforces at private equity-acquired versus non-private equity-acquired dermatology, ophthalmology, and gastroenterology practices between 20

Hospitals 101
article thumbnail

11 ways to relieve insomnia from quitting smoking

The Checkup by Singlecare

If you’re considering quitting smoking, or have recently given it up, congratulations! No matter how long you’ve been smoking, quitting is one of the best things you can do for your health. But for all its benefits—and there are many !—it’s not an easy road. You can expect withdrawal symptoms to peak at three days after stopping (and to subside within a month).

article thumbnail

Pediatricians recommend weight-loss drugs and surgery for children with obesity

STAT

Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting,” or delaying treatment to see whether children and teens outgrow or overcome obesity on their own only worsens the problem that affects more than 14.4 million young people in the U.S.

101
101
article thumbnail

US FDA approves Eisai-Biogen’s antibody for Alzheimer’s

Pharmaceutical Technology

Eisai and Biogen have received approval for their antibody Leqembi (lecanemab-irmb) , 100mg/mL injection for intravenous use, from the US Food and Drug Administration (FDA) under the Accelerated Approval Pathway to treat Alzheimer’s disease (AD). Leqembi is indicated to treat mild cognitive impairment or mild dementia stage of the disease in patients whose treatment started in clinical trials.

FDA 98
article thumbnail

Opinion: Four types of bias in medical AI are running under the FDA’s radar

STAT

Although artificial intelligence is entering health care with great promise, clinical AI tools are prone to bias and real-world underperformance from inception to deployment, including the stages of dataset acquisition, labeling or annotating, algorithm training, and validation. These biases can reinforce existing disparities in diagnosis and treatment.

Labelling 101